<qa>  How many cohorts of 3-6 patients receive Tf-CRM107?- Group 2 ages 10-18: Patients receive intratumoral Tf-CRM107 as in group 1. Two cohorts of 3-6 patients receive escalating doses of Tf-CRM107 until the MTD is determined. 